Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn’s Disease Patient on Combination Immunosuppression
Open Access
- 19 January 2025
- journal article
- research article
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2025 (1) , 6088333
Abstract
Novel therapeutics used in the treatment of inflammatory bowel disease pose an increased risk of viral reactivation in patients. We present a case of a patient with refractory Crohn’s disease (CD) who developed primary varicella (chickenpox) of a vaccine‐viral strain after receiving combination immunosuppression with high‐dose corticosteroids, tumor necrosis factor inhibitor (TNFi), and a Janus kinase inhibitor (JAKi) in the hospital. While this patient recovered and did not experience long term adverse effects, her case provides an opportunity for improvement. To improve safety, healthcare facilities should develop protocols that use electronic medical records enhanced with clinical decision support systems to identify and protect immunocompromised patients from inappropriate live vaccinations.Keywords
This publication has 14 references indexed in Scilit:
- In-hospital management of inflammatory bowel diseaseCurrent Opinion in Gastroenterology, 2023
- Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the LiteratureDigestive Diseases and Sciences, 2023
- Safety Surveillance of Varicella Vaccines in the Vaccine Adverse Event Reporting System, United States, 2006–2020The Journal of Infectious Diseases, 2022
- Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control StudyClinical Gastroenterology and Hepatology, 2021
- Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical TrialsClinical Gastroenterology and Hepatology, 2019
- Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving TofacitinibInflammatory Bowel Diseases, 2018
- Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and PreventionInflammatory Bowel Diseases, 2018
- ACG Clinical Guideline: Preventive Care in Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2017
- Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised HostClinical Infectious Diseases, 2014
- The Safety Profile of Varicella Vaccine: A 10‐Year ReviewThe Journal of Infectious Diseases, 2008